| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Published online before print May 3, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,
,
From Surgical Research,* the Department of Surgery, Brown University School of Medicine and Rhode Island Hospital, Providence; and the Departments of Medicine
and Molecular Microbiology and Immunology,
Brown University School of Medicine, Providence, Rhode Island
@ To whom correspondence should be addressed. E-mail: aayala{at}lifespan.org.
| Abstract |
|---|
Although studies blocking the Fas pathway indicate it can decrease organ damage while improving septic (cecal ligation and puncture, CLP) mouse survival, little is known about how Fas-Fas ligand (FasL) interactions mediate this protection at the tissue level. Here, we report that although Fas expression on splenocytes and hepatocytes is up-regulated by CLP and is inhibited by in vivo short interfering RNA, FasL as well as the frequency of CD8+ T cells are differentially altered by sepsis in the spleen (no change in FasL, decreased percentage of CD8+ and CD4+ T cells) versus the liver (increased FasL expression on CD8+ T cells and increase in percentage/number). Adoptive transfer of CLP FasL+/+ versus FasL-/- mouse liver CD8+ T cells to severe combined immunodeficient or RAG1-/- recipient mice indicated that these cells could induce inflammation. The FasL-mediated cytotoxic capacity of these septic mouse liver CD8+ T cells was shown by their ability to damage directly cultured hepatocytes. Finally, although CD8-/- mice exhibited a reduction in both CLP-induced liver active caspase-3 staining and blood interleukin-6 levels, only FasL-/- (but not CD8-/-) protected the septic mouse spleen from increasing apoptosis. Thus, although truncating Fas-FasL signaling ameliorates many untoward effects of sepsis, the pathological mode of action is distinct at the tissue level.
This article has been cited by other articles:
![]() |
D. Londono, A. Marques, R. L. Hornung, and D. Cadavid IL-10 Helps Control Pathogen Load during High-Level Bacteremia J. Immunol., August 1, 2008; 181(3): 2076 - 2083. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |